|
Lionel Messi Vs Hepatitis C
(closed)
(Preview)
#stopthespam -- Edited by JimmyK on Sunday 7th of May 2017 09:33:19 AM
|
Ultraviolet1
|
2
|
1416
|
|
|
|
Hep C Hope
(Preview)
Here is a website and organization that offers good information, resources and insight into Hep C. It's a good site to bookmark. Hep C Hope
|
Tig
|
3
|
1527
|
|
|
|
|
AASLD Recommendations for testing, treating and managing HCV
(Preview)
I came across this report and found it interesting. Is fairly recent and discusses current treatment recommendations for all genotypes. I thought you might find it informative as well. Tig INITIAL TREATMENT OF HCV INFECTION IN PATIENTS STARTING TREATMENT Updated 09/16
|
Tig
|
11
|
2948
|
|
|
|
|
Wonder what they're building with them antibodies?
(Preview)
Someday, one day, (eventually) all these people all over the world who are holed up in labs trying to come up with immunization to prevent contracting HCV, will succeed! In the interim yay for "novel" drug research as without it we would not be where we are today, being cured of HCV with the new DAA's. Ah...
|
Canuck
|
9
|
1881
|
|
|
|
|
Hepatitis B treatment and cure
(closed)
(Preview)
Post removed because forum advertising of herbal cures and services is not allowed. This is a thread that deals specifically with Hepatitis C. Please read and follow our forum guidelines before posting. I am closing this thread. Tig56 - Forum Administrator -- Edited by Tig56 on Thursday 9th of Marc...
|
stacey09
|
0
|
1135
|
|
|
|
|
ALF- Liver Life Walk
(Preview)
What is Liver Life Walk?The Liver Life Walk® is the national fundraising walk of the American Liver Foundation®. Join more than 10,000 people from coast-to-coast to change the face of liver health!Your fundraising and participation will bring awareness to liver disease and provide financial s...
|
Tig
|
0
|
1281
|
|
|
|
|
Feb 2017 FDA Update HBV Reactivation Labeling Revisions
(Preview)
On February 14, 2017 FDA approved class labeling revisions regarding the risk of hepatitis B virus reactivation in patients coinfected with hepatitis C virus (HCV) and hepatitis B virus (HBV). The class labeling applies to the following HCV direct acting antiviral (DAA) agents:Daklinza (dacl...
|
Tig
|
1
|
1339
|
|
|
|
|
American Liver Fdn, NYC Half Marathon 2017
(Preview)
Please help us spread the word. The American Liver Foundation has guaranteed race entries to the NYC Half Marathon (March 19th). The fundraising commitment is low and achievable. Committing to running a half marathon while supporting a great cause is a great way to start the year. Register for...
|
Tig
|
0
|
1308
|
|
|
|
|
New (revised) ALT levels - 2 (cont'd.)
(Preview)
More tidbits, starting to trickle out, about the new ALT levels, "Liver Tests" and other destined changes to guidelines: Medscape Medical NewsLiver Test Guidelines Updated by ACGVeronica Hackethal, MDJanuary 12, 2017The American College of Gastroenterology (ACG) has released updated gu...
|
Canuck
|
2
|
1622
|
|
|
|
|
Fake Harvoni Warning
(Preview)
Just found an article and warning about some fake Harvoni dispensed at a Japanese pharmacy. This is something everyone should be conscious of, especially those dealing with generics. Buyer beware. We'll have to follow this. Article here: FAKE
|
Tig
|
0
|
1481
|
|
|
|
|
Zepatier Effective for Retreatment
(Preview)
Some continuing good news regarding Zepatier. "Zepatier treatment for 12 weeks, with or without ribavirin, was highly effective for induction of sustained virologic response in patients infected with hepatitis C genotypes 1, 4 or 6, who failed prior peg-interferon and ribavirin treatments...
|
Tig
|
0
|
1526
|
|
|
|
|
New (revised) ALT levels
(closed)
(Preview)
1. Healio GUIDELINESNew ACG guideline on liver chemistries lowers normal ALT levelKwo PY. Am J Gastroenterol. 2016;doi:10.1038/ajg.2016.517.December 21, 2016The American College of Gastroenterology has published the first new guideline in over 10 years on the evaluation of abnorm...
|
Canuck
|
6
|
2776
|
|
|
|
|
Most recent ALERT regarding HCV and HBV
(Preview)
http://www.hepatitiscentral.com/news/fda-now-requires-boxed-warning-on-hcv-drugs-harvoni-sovaldi-daklinza-and-more/?eml=special161005
|
Binalovina
|
10
|
2079
|
|
|
|
|
Better Ultrasounds
(Preview)
FDA NEWSFDA grants 510(k) clearance to new ultrasound modes for liver, breast imagingNovember 22, 2016SuperSonic Imagine announced the FDA granted 510(k) clearance to add additional imaging probes - for liver disease and breast lesions - for use with its Aixplorer platform.Aixplorer (Super...
|
Canuck
|
2
|
1747
|
|
|
|
|
HIV Glasgow: Generic Hepatitis C Drugs Purchased Online Produce High Cure Rates
(Preview)
Hi all, I am new here. This is the article I just saw. Hope to share it as a "Hello" Use of generic versions of direct-acting antivirals for hepatitis C resulted in very high cure rates for people who obtained the products through 3 buyers clubs, indicating that the generic products are effective, acco...
|
HieuPham
|
1
|
1569
|
|
|
|
|
Hep C Trust considering seeking judicial review of NHS England`s decision to ration access to new NICE approved drugs
(Preview)
I`m posting this as it`s such an important issue for anyone in England who is currently waiting for treatment with the new DAA medicines. The Hep C Trust is a well respected charity and advocate for HCV, and they are asking for support to fight NHS England`s decision through the courts...The Hepatit...
|
Cinnamon Girl
|
9
|
2481
|
|
|
|
|
Newest EASL HCV Recommendations - Sept 2016
(Preview)
Newest EASL HCV Recommendations http://www.easl.eu/medias/cpg/HCV2016/English-report.pdfBut to save you all that reading, below is a "shorter" article about some of it: I note...
|
Canuck
|
1
|
2306
|
|
|
|
|
NICE (UK) publishes draft guidance recommending Sof/Vel for use within NHS
(Preview)
NICE has published new draft guidance which recommends sofosbuvir-velpatasvir. The NICE appraisal committee concluded that sofosbuvir-velpatasvir was clinically and cost-effective, and should be routinely available on the NHS.Sofosbuvir-velpatasvir - a tablet taken once daily - works...
|
Cinnamon Girl
|
2
|
1396
|
|
|
|
|
New Hep C documentary
(Preview)
This will hopefully be an interesting and factual look into the Hep C epidemic facing so many countries today, as sufferers try to obtain life-saving treatment."Deal with it: Untold Stories of Hepatitis C in Canada", at least, addresses the issues. Take care all- [video=https://www.youtube....
|
dharmabum
|
6
|
2021
|
|
|
|
|
Test for HBV before DAA treatment, new guidelines from AASLD
(Preview)
[url=http://hepatitisc.hcvadvocate.org/2016/09/new-guidance-test-for-h...
|
Cinnamon Girl
|
2
|
1580
|
|
|
|
|
Highly detailed article on DAA resistance
(Preview)
A very complex article for my brain :( but very worth reading freepdfhosting.com/b3d39c5e48.pdf
|
HieuPham
|
6
|
2361
|
|
|
|
|
Sovaldi/Harvoni in France
(Preview)
France gets larger discount on Sovaldi than its neighborsNov 20 2014, 12:04 ET | By: Douglas W. House, SA News Editor France's hard line negotiations with Gilead Sciences (GILD -0.1%) over Sovaldi (sofosbuvir) pricing paid off. The agreed-upon price per box will be 13,667 Euros which is 5,...
|
Isiscat2011
|
16
|
6303
|
|
|
|
|
UNIQUE PATIENT POPULATIONS: PATIENTS WITH DECOMPENSATED CIRRHOSIS
(Preview)
The current AASLD summary of recommendations for patients with decompensated cirrhosis:UNIQUE PATIENT POPULATIONS: PATIENTS WITH DECOMPENSATED CIRRHOSIS
|
Tig
|
0
|
1209
|
|
|
|
|
European Commission Approves Zepatier GT 1 and 4
(Preview)
European Commission approves Zepatier for HCV genotypes 1, 4 August 1, 2016 Merck announced the European Commission granted marketing authorization for Zepatier to treat adult patients with chronic hepatitis C virus genotype 1 and 4 infection, with or without ribavirin, according to a comp...
|
Tig
|
1
|
1786
|
|
|
|
|
Epclusa and Vox
(Preview)
Gossipy stuff / Marketing type interview ...GILD's plans for its HCV treatments: clear and conciseThe company's EVP and CSO, Norbert Bischofberger, presented last week at a Goldman Sachs (NYSE:GS) conference. One of his comments about GILD's HCV plans was quite revealing. He said:That is the...
|
Canuck
|
4
|
2270
|
|
|
|
|
AbbVie Receives U.S. FDA Approval of Once-Daily VIEKIRA XR for GT 1
(Preview)
Once daily VIEKIRA XR has been approved by the US FDA for Genotype 1. VIEKIRA XR FDA APPROVAL
|
Tig
|
0
|
1546
|
|
|
|
|
AASLD/IDSA HCV GUIDELINE UPDATE JULY 2016
(Preview)
Updated HCV guidelines have been released by the AASLD (American Assoc. for the Study of Liver Disease) and the IDSA (Infectious Disease Society of America).Multiple sections of the guidance posted on HCVguidelines.org have been revised to reflect the FDAs approval of Epclusa (sofosbuvir/vel...
|
Tig
|
6
|
1907
|
|
|
|
|
CROI 2016: Viral Hepatitis and Liver Fibrosis
(Preview)
More information from the Conference on Retroviruses and Opportunistic Infections (CROI) 2016. In PDF format and technical, but is very informative and separated into easy to find subjects that may be of interest to you. Viral Hepatitis and Liver Fibrosis
|
Tig
|
5
|
1287
|
|
|
|
|
Dear Baby Boomers: Hep C Isn't Your Fault
(Preview)
I thought this was an interesting article and wanted to share it with those of you that continue to wonder about where or how they contracted this evil disease. Doesn't matter in the big picture, getting rid of it is. But the school of thought may be changing. This was published by the Lancet recently an...
|
Tig
|
7
|
2110
|
|
|
|
|
EMA panel recommends approval of Epclusa (Sov/Velpa) for all HCV genotypes
(Preview)
May 27, 2016 The European Committee for Medicinal Products for Human Use granted a positive opinion for Gilead Sciences Marketing Authorization Application for Epclusa for the treatment of all chronic hepatitis C genotypes, according to a press release from the manufacturer. Epclusa (s...
|
Tig
|
9
|
1745
|
|
|
